CLINICAL_TRIALS
trial_result
· 2013-11-01
Clinical Trial Update: UVB-311nm After Initial Slow Response to Adalimumab in Psoriasis [NA]
Summary
This clinical trial update describes using UVB-311nm phototherapy after an initial slow response to adalimumab in psoriasis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medical University of Graz | Conditions: Psoriasis | NA | Status: UNKNOWN